The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Tamoxifen resistance by a conformational arrest of the estrogen receptor α after PKA activation in breast cancer
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
The nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964
Yang, Y. H. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.4.e15 · Cited by 3,464
Shiau, A. K., Barstad, D., Loria, P. M., Cheng, L., Kushner, P. J., Agard, D. A., & Greene, G. L. (1998) · Cell · doi:10.1016/s0092-8674(00)81717-1 · Cited by 2,729
Functional Discovery via a Compendium of Expression Profiles
Hughes, T. R., Marton, M. J., Jones, A. R., Roberts, C. J., Stoughton, R., Armour, C. D., Bennett, H. A., Coffey, E., Dai, H., He, Y. D., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00015-5 · Cited by 2,533
Creating new fluorescent probes for cell biology
Zhang, J., Campbell, R. E., Ting, A. Y., & Tsien, R. Y. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm976 · Cited by 1,981
Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
Kato, S., Endoh, H., Masuhiro, Y., Kitamoto, T., Uchiyama, S., Sasaki, H., Masushige, S., Gotoh, Y., Nishida, E., Kawashima, H., et al. (1995) · Science · doi:10.1126/science.270.5241.1491 · Cited by 1,964
Molecular Determinants for the Tissue Specificity of SERMs
Shang, Y., & Brown, M. (2002) · Science · doi:10.1126/science.1068537 · Cited by 1,146
Stable suppression of tumorigenicity by virus-mediated RNA interference
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00122-8 · Cited by 886
Endocrine-responsive breast cancer and strategies for combating resistance
Ali, S., & Coombes, R. C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc721 · Cited by 883
CDK-Independent Activation of Estrogen Receptor by Cyclin D1
Zwijsen, R. M. L., Wientjens, E., Klompmaker, R., van der Sman, J., Bernards, R., & Michalides, R. J. A. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81879-6 · Cited by 720
Self-citationHowell, A., Robertson, J. F. R., Quaresma Albano, J., Aschermannova, A., Mauriac, L., Kleeberg, U. R., Vergote, I., Erikstein, B., Webster, A., & Morris, C. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.10.057 · Cited by 671
Osborne, C. K., Pippen, J., Jones, S. E., Parker, L. M., Ellis, M., Come, S., Gertler, S. Z., May, J. T., Burton, G., Dimery, I., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.10.058 · Cited by 642
Pietras, R. J., Arboleda, J., Dm, R., Wongvipat, N., Pegram, M. D., Ramos, L., Cm, G., Mg, P., Sliwkowski, M. X., & Dj, S. (1995) · PubMed · Cited by 603
The nuclear receptor superfamily
Robinson-Rechavi, M., Garcia, H. E., & Laudet, V. (2003) · Journal of Cell Science · doi:10.1242/jcs.00247 · Cited by 587
Le Goff, P., Montano, M. M., Schodin, D. J., & Katzenellenbogen, B. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41801-1 · Cited by 452
Normalization for cDNA microarry data:
Yang, Y. H., Dudoit, S., Luu, P., & Speed, T. P. (2001) · SPIE Proceedings · doi:10.1117/12.427982 · Cited by 442
Smith, C. L., Oñate, S. A., Tsai, M. J., & O'Malley, B. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.8884 · Cited by 414
Peptide Antagonists of the Human Estrogen Receptor
Norris, J. D., Paige, L. A., Christensen, D. J., Chang, C.-Y., Huacani, M. R., Fan, D., Hamilton, P. T., Fowlkes, D. M., & McDonnell, D. P. (1999) · Science · doi:10.1126/science.285.5428.744 · Cited by 373
Selective Estrogen Receptor Modulators: Structure, Function, and Clinical Use
Osborne, C. K., Zhao, H. (., & Fuqua, S. A. W. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.17.3172 · Cited by 367
Osborne, C. K., Coronado-Heinsohn, E. B., Hilsenbeck, S. G., McCue, B. L., Wakeling, A. E., McCleland, R. A., Manning, D. L., & Nicholson, R. I. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.10.746 · Cited by 361
Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer
Howell, A., DeFriend, D. J., Blamey, R. W., Robertson, J. F., & Walton, P. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91156-1 · Cited by 349
Structural Insights into the Mode of Action of a Pure Antiestrogen
Pike, A. C. W., Brzozowski, A. M., Walton, J., Hubbard, R. E., Thorsell, A.-G., Li, Y.-L., Gustafsson, J.-Å., & Carlquist, M. (2001) · Structure · doi:10.1016/s0969-2126(01)00568-8 · Cited by 347
Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1
Zwijsen, R. M. L., Buckle, R. S., Hijmans, E. M., Loomans, C. J. M., & Bernards, R. (1998) · Genes & Development · doi:10.1101/gad.12.22.3488 · Cited by 305
Phosphorylation of Human Estrogen Receptor α by Protein Kinase A Regulates Dimerization
Chen, D., Pace, P. E., Coombes, R. C., & Ali, S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1002 · Cited by 260
Wagner, B. L., Norris, J. D., Knotts, T. A., Weigel, N. L., & McDonnell, D. P. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.3.1369 · Cited by 255
van der Wal, J., Habets, R., Várnai, P., Balla, T., & Jalink, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007194200 · Cited by 241
Self-citationKraus, W. L., McInerney, E. M., & Katzenellenbogen, B. S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12314 · Cited by 203
HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading
van Ham, S. M., Tjin, E. P. M., Lillemeier, B. F., Grüneberg, U., van Meijgaarden, K. E., Pastoors, L., Verwoerd, D., Tulp, A., Canas, B., Rahman, D., et al. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00414-3 · Cited by 163
Self-citationcAMP abrogates the p21ras-mitogen-activated protein kinase pathway in fibroblasts.
Hordijk, P. L., Verlaan, I., Jalink, K., van Corven, E. J., & Moolenaar, W. H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41896-5 · Cited by 158
Self-citationSelective estrogen receptor modulators (SERMS) and their roles in breast cancer prevention
Park, W., & Jordan, V. C. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02282-7 · Cited by 144
Métivier, R., Stark, A., Flouriot, G., Hübner, M. R., Brand, H., Penot, G., Manu, D., Denger, S., Reid, G., Koš, M., et al. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00746-3 · Cited by 143
Duggin, G. G., Dale, N. E., Lyneham, R. C., Evans, R. A., & TILLER, D. J. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92395-8 · Cited by 129
O'Regan, R. M., & Jordan, V. C. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00711-8 · Cited by 126
Cyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatment
Michalides, R. J. A. M., van Tinteren, H., Balkenende, A., Vermorken, J. B., Benraadt, J., Huldij, J. C., & van Diest, P. J. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600072 · Cited by 115
Self-citationRegulation of estrogen receptor transcriptional enhancement by the cyclin A/Cdk2 complex
Trowbridge, J. M., Rogatsky, I., & Garabedian, M. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10132 · Cited by 98
Hopp, T. A., & Fuqua, S. A. W. (1998) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1018726418931 · Cited by 65
Bindels, E. M., Lallemand, F., Balkenende, A., Verwoerd, D., & Michalides, R. J. A. M. (2002) · Oncogene · doi:10.1038/sj.onc.1206012 · Cited by 54
Self-citation
Cited by
Principles for modulation of the nuclear receptor superfamily
Gronemeyer, H., Gustafsson, J.-Å., & Laudet, V. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1551 · Cited by 1,226
Integration of the extranuclear and nuclear actions of estrogen
Levin, E. R. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0390 · Cited by 708
p21-activated kinases in cancer
Kumar, R., Gururaj, A. E., & Barnes, C. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1892 · Cited by 604
Extranuclear Steroid Receptors: Nature and Actions
Hammes, S. R., & Levin, E. R. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0022 · Cited by 475
p21 and p27: roles in carcinogenesis and drug resistance
Abukhdeir, A. M., & Park, B. H. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000744 · Cited by 463
Metadata
- Authors
- Michalides, R., Griekspoor, A., Balkenende, A., Verwoerd, D., Janssen, L., Jalink, K., Floore, A., Velds, A., van `t Veer, L., & Neefjes, J.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2004-06
- Volume
- 5
- Issue
- 6
- Pages
- 597-605
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2071901592
- Cited by
- 260
- References
- 38
- FWCI
- 14.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.